Back | Next |
home / stock / mgnx / mgnx message board
News, Short Squeeze, Breakout and More Instantly...
2024-07-29 07:15:06 ET Barclays analyst issues OVERWEIGHT recommendation for MGNX on July 29, 2024 05:41AM ET. The previous analyst recommendation was Overweight. MGNX was trading at $5.55 at issue of the analyst recommendation. The overall analyst consensus : BUY. C...
2024-07-29 07:00:10 ET Peter Lawson from Barclays issued a price target of $9.00 for MGNX on 2024-07-29 05:41:00. The adjusted price target was set to $9.00. At the time of the announcement, MGNX was trading at $5.55. The overall price target consensus is at $15.43 with ...
MacroGenics, Inc. (NASDAQ: MGNX) is the focus of IBN's latest stock spotlight. The company's shares have moved 1.9% on the day to $5.35. MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved pr...